Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned an average rating of “Hold” from the seven research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $40.00.

RHHBY has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a research note on Friday, May 17th. Argus restated a “hold” rating on shares of Roche in a research report on Monday, March 4th.

Roche Stock Performance

RHHBY stock opened at $31.60 on Monday. The business’s fifty day moving average is $31.02 and its 200-day moving average is $33.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.35 and a quick ratio of 1.04. Roche has a twelve month low of $29.20 and a twelve month high of $40.48.

Hedge Funds Weigh In On Roche

A number of large investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. increased its holdings in Roche by 19.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock worth $75,000 after purchasing an additional 342 shares in the last quarter. Bard Financial Services Inc. increased its holdings in Roche by 2.0% during the 1st quarter. Bard Financial Services Inc. now owns 20,200 shares of the company’s stock worth $645,000 after purchasing an additional 400 shares in the last quarter. SVB Wealth LLC increased its holdings in Roche by 2.6% during the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after purchasing an additional 426 shares in the last quarter. Hancock Whitney Corp increased its holdings in Roche by 2.4% during the 1st quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after purchasing an additional 678 shares in the last quarter. Finally, AlphaMark Advisors LLC bought a new position in Roche during the 1st quarter worth about $34,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.